The FDA grants de novo clearance to Johnson & Johnson subsidiary Ethicon Endo-Surgery's Percutaneous Surgical Set; European resolutions post-breast implant scare raise eyebrows among device makers; FDA grants PMA to Medinol's Presillion coronary stent; Nephros lands 510(k) for Hemodiafiltration; Toshiba touts FDA clearance for Aquilion Prime 80 CT system; Theragenics scores FDA clearance for Market Galt valved tearaway introducer; Spectranetics wins FDA clearance for its GlideLight laser sheath; and more.

Johnson & Johnson (NYSE:JNJ) Ethicon Endo-Surgery won FDA clearance for the 1st surgical instruments that can be assembled and disassembled inside the body during surgery.
A Delaware jury sides with Johnson & Johnson's DePuy-Synthes subsidiary in a patent spat over 3...
Results of pivotal study on Covidien subsidiary eV3's Pipeline cerebral aneurysm device, published in...
Delphi Ventures' John Maroney joins ForSight Vision5 as president, CEO & Director as the...
Echo Therapeutics initiates discussions with the FDA on the regulatory pathway for its Symphony non-...
Study results revealed in Europe this week cast doubt on the efficacy of renal denervation for...